Ansell Ltd (ASX: ANN) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Ansell Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $2.93 billion
P/E Ratio 13.36
Dividend Yield 2.75%
Shares Outstanding 124.79 million
Earnings per share 1.167
Dividend per share 0.66
Year To Date Return -4.36%
Earnings Yield 7.48%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Ansell Ltd (ASX: ANN)
    Latest News

    A man looks down with fright as he falls towards the ground.
    Share Fallers

    8 ASX shares that were COVID winners but have now crashed

    They were the skyrocketing ASX shares of the pandemic. But that was then...

    Read more »

    A woman sits at a table with notebook on lap and pen in hand as she gazes off to the side with the pen resting on the side of her face as though she is thinking and contemplating while a glass of orange juice and a pair of red sunglasses rests on the table beside her.
    Broker Notes

    How this fundie plans to keep investing through a recession

    There are still fears the United States could go into a recession this year.

    Read more »

    A woman looks quizzical while looking at a dollar sign in the air.
    How to invest

    My $10-a-day approach to building a second income with ASX shares

    Creating a long-term passive income doesn't have to break the bank.

    Read more »

    Broker Notes

    Morgans warns that these ASX shares could disappoint in FY23

    Investors may expecting too much from these ASX shares in the second half...

    Read more »

    a man in a business suit holds his hand up to his mouth as though sharing a secret and gives a sly grin.
    Share Market News

    6 ASX 200 directors buying up their company shares in the past week

    Are insiders hopeful of the future for these ASX 200 stocks?

    Read more »

    Young female AGL investor leans back in her desk chair feeling relieved after the AGL share price soared today
    Opinions

    I'd invest $5,000 into these excellent ASX shares for the long term

    Each of these ASX shares seem like great ideas to me.

    Read more »

    A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
    Dividend Investing

    8 ASX 200 shares trading ex-dividend this week

    Aspiring income investors better get in quick if they want a piece of these upcoming dividends.

    Read more »

    A man looks down with fright as he falls towards the ground.
    Share Fallers

    Why Ansell, Breville, Star, and Temple & Webster shares are falling

    These ASX shares are having a tough session on Tuesday and are deep in the red...

    Read more »

    Health professional putting on gloves.
    Earnings Results

    Ansell share price slumps 8% as healthcare sales fail to cough up

    It's time to put on the gloves and pick apart this doozy of a report.

    Read more »

    Health professional putting on gloves.
    Healthcare Shares

    Is this share the ASX 200's best healthcare buy?

    Could 2023 be Ansell's time to shine?

    Read more »

    A man and woman jump in the air and high five with both hands on a road after running.
    Investing Strategies

    'No signs of weakness': Expert names 2 ASX shares to buy just starting their rise

    Here is a pair of stocks going gangbusters, but it may not be too late to jump on the bandwagon.

    Read more »

    Woman on her laptop thinking to herself.
    Broker Notes

    2 ASX shares to buy that you haven't even thought about: expert

    An expert has picked a pair of stocks to invest in right now that are primed to take advantage of…

    Read more »

    Frequently Asked Questions

    Yes, Ansell has historically paid two unfranked or partially franked dividends per year.

    Ansell pays its shareholder dividends in March and September.

    Ansell Ltd listed on the ASX on 22 August 1985.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    26 Feb 2024 $0.2521 0.00% Interim 14 Mar 2024
    18 Aug 2023 $0.4031 0.00% Final 07 Sep 2023
    20 Feb 2023 $0.2915 0.00% Interim 09 Mar 2023
    29 Aug 2022 $0.4518 0.00% Final 15 Sep 2022
    21 Feb 2022 $0.3367 0.00% Interim 09 Mar 2022
    30 Aug 2021 $0.5944 0.00% Final 16 Sep 2021
    22 Feb 2021 $0.4190 0.00% Interim 10 Mar 2021
    31 Aug 2020 $0.3811 0.00% Final 17 Sep 2020
    24 Feb 2020 $0.3288 0.00% Interim 12 Mar 2020
    16 Aug 2019 $0.3833 0.00% Final 05 Sep 2019
    22 Feb 2019 $0.2905 0.00% Interim 14 Mar 2019
    24 Aug 2018 $0.3414 0.00% Final 13 Sep 2018
    16 Feb 2018 $0.2588 44.13% Interim 08 Mar 2018
    18 Aug 2017 $0.2998 0.00% Final 08 Sep 2017
    17 Feb 2017 $0.2638 0.00% Interim 10 Mar 2017
    19 Aug 2016 $0.3097 0.00% Final 08 Sep 2016
    11 Feb 2016 $0.2795 0.00% Interim 10 Mar 2016
    13 Aug 2015 $0.3119 0.00% Final 10 Sep 2015
    12 Feb 2015 $0.2567 0.00% Interim 11 Mar 2015
    26 Feb 2014 $0.1828 0.00% Interim 25 Mar 2014
    16 Feb 2012 $0.1050 0.00% Interim 14 Mar 2012
    17 Feb 2011 $0.0980 0.00% Interim 16 Mar 2011
    31 Aug 2010 $0.1225 0.00% Final 29 Sep 2010
    02 Mar 2006 $0.0630 0.00% Interim 07 Apr 2006
    26 Sep 2005 $0.0700 0.00% Final 18 Oct 2005

    ANN ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Ansell Ltd

    Ansell Ltd (ASX: ANN) is a leading global supplier of protective gloves and bodywear for use in healthcare and industrial settings.

    The company holds a large number of patents and the majority of sales come from its key branded product ranges. It earns the bulk of its revenue and profit from the healthcare segment and the remainder from its industrial business.

    The Australian company has an international manufacturing and distribution footprint and supplies its products via key partners as well as directly across more than 120 countries.

    Ansell earns the bulk of its revenue from its North American market segment followed by Europe, the Middle East, and Africa. The Asia-Pacific accounts for a relatively small portion of the company's business.

    ANN Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    01 Mar 2024 $23.48 $-0.35 -1.47% 263,022 $23.94 $23.97 $23.40
    29 Feb 2024 $23.83 $-0.12 -0.50% 376,895 $23.97 $24.01 $23.67
    28 Feb 2024 $23.95 $-0.18 -0.75% 356,767 $24.26 $24.39 $23.88
    27 Feb 2024 $24.13 $-0.42 -1.71% 255,912 $24.46 $24.74 $23.99
    26 Feb 2024 $24.55 $-0.10 -0.41% 436,449 $24.50 $25.05 $24.43
    23 Feb 2024 $24.65 $-0.20 -0.80% 318,146 $24.80 $25.13 $24.65
    22 Feb 2024 $24.85 $0.59 2.43% 506,918 $24.26 $25.08 $24.13
    21 Feb 2024 $24.26 $0.63 2.67% 498,077 $23.52 $24.41 $23.52
    20 Feb 2024 $23.63 $-0.50 -2.07% 587,427 $23.86 $24.33 $23.04
    19 Feb 2024 $24.13 $-0.05 -0.21% 239,966 $24.13 $24.22 $23.94
    16 Feb 2024 $24.18 $0.09 0.37% 205,849 $24.44 $24.48 $24.14
    15 Feb 2024 $24.09 $-0.04 -0.17% 221,049 $24.04 $24.40 $23.94
    14 Feb 2024 $24.13 $-0.02 -0.08% 146,811 $23.87 $24.21 $23.81
    13 Feb 2024 $24.15 $0.12 0.50% 162,572 $23.97 $24.30 $23.89
    12 Feb 2024 $24.03 $-0.43 -1.76% 279,462 $24.45 $24.50 $23.95
    09 Feb 2024 $24.46 $0.03 0.12% 264,560 $24.37 $24.66 $24.31
    08 Feb 2024 $24.43 $-0.29 -1.17% 301,363 $24.72 $24.73 $24.35
    07 Feb 2024 $24.72 $-0.04 -0.16% 358,017 $24.79 $24.89 $24.66
    06 Feb 2024 $24.76 $0.21 0.86% 292,297 $24.35 $24.76 $24.21
    05 Feb 2024 $24.55 $-0.03 -0.12% 187,677 $24.32 $24.55 $24.06
    02 Feb 2024 $24.58 $0.49 2.03% 490,481 $24.15 $24.58 $23.96
    01 Feb 2024 $24.09 $-0.06 -0.25% 299,005 $24.15 $24.20 $23.80

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    19 Dec 2023 Neil Salmon Issued 10,198 $244,987
    Issue of securities.
    30 Nov 2023 Neil Salmon Issued 72,263 $1,714,078
    Issue of securities. 167,791 - PSRs
    23 Nov 2023 Christina Stercken Buy 285 $6,499
    Participation in share purchase plan.
    06 Nov 2023 Christina Stercken Buy 294 $6,491
    Participation in share purchase plan.
    30 Oct 2023 Christina Stercken Buy 800 $16,880
    On-market trade.
    27 Oct 2023 Nigel Garrard Buy 1,250 $26,500
    On-market trade.
    12 Sep 2023 Christina Stercken Buy 837 $18,742
    Participation in share purchase plan.
    07 Sep 2023 Debra (Debbie) Goodin Buy 8 $1,492
    Dividend Reinvestment Plan (DRP).
    23 Aug 2023 Christine Yan Buy 8,300 $191,893
    On-market trade.
    18 Aug 2023 Neil Salmon Expiry 30,271 $705,011
    As advised by the company. Lapsing of PSRs
    95,428 - PSRs
    18 Aug 2023 Christine Yan Buy 283 $6,670
    Participation in share purchase plan.
    18 Aug 2023 John Bevan Buy 172 $4,054
    Participation in share purchase plan.
    18 Aug 2023 Debra (Debbie) Goodin Buy 418 $9,816
    On-market trade.
    18 Aug 2023 Christina Stercken Buy 260 $6,128
    Participation in share purchase plan.
    17 Aug 2023 Nigel Garrard Buy 1,000 $23,970
    On-market trade.
    31 May 2023 John Bevan Buy 149 $3,990
    Participation in share purchase plan.
    31 May 2023 Christina Stercken Buy 227 $6,079
    Participation in share purchase plan.
    31 May 2023 Christine Yan Buy 246 $6,587
    Participation in share purchase plan.
    02 May 2023 Christine Yan Buy 480 $13,007
    Participation in share purchase plan.
    02 May 2023 John Bevan Buy 292 $7,912
    Participation in share purchase plan.
    02 May 2023 Christina Stercken Buy 441 $11,950
    Participation in share purchase plan.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Nigel David Garrard Non-Executive Director Mar 2020
    Mr Garrard is an executive who has worked across FMCG and Industrial/ Manufacturing sectors. Mr Garrard has 20 years of experience as an ASX-listed CEO across three companies. In 2019, Mr Garrard retired as Managing Director and CEO of Orora Limited. Mr Garrard led the demerger of Orora from Amcor, and subsequent listing on the ASX in 2013. Mr Garrard brings international experience across listed, not-for-profit, governance, private and industry entities. He is the Chair of the Human Resources Committee and member of the Sustainability and Risk Committee and Share Buyback Sub-Committee.
    Mr William G Reilly Non-Executive Director Oct 2017
    Mr Reilly has over 35 years of experience as an in-house lawyer. Mr Reilly was appointed as General Counsel of Ansell Healthcare in 2000 when it was a division of Pacific Dunlop Limited, subsequently becoming General Counsel of Ansell Limited in 2002.Mr Reilly has served with three Chief Executive Officers and has played roles leading many of Ansell's corporate strategic and legal initiatives, including M&A, litigation, and the intellectual property strategy. He has also overseen the Global Compliance and Risk functions, acted as interim head of Human Resources, leader of the Regulatory function and joint Company Secretary. He is member of the Sustainability and Risk Committee, the Human Resources Committee, the Governance Committee, and the M&A Sub-Committee.
    Ms Debra (Debbie) Lyn Goodin Non-Executive Director Dec 2022
    Ms Goodin is an executive who has global experience in operations, finance, M&A, and corporate services, and has worked in both the public and private sectors. In 2014 she completed a 22-month contract role with Downer Group (ASX 100) as Divisional CEO/COO of Downer's two consulting subsidiary companies in New Zealand and Australia. Prior to this Ms Goodin was the Global COO of Coffey International where she led a range of engineering consulting businesses in the areas of mining, geotechnics, environment, and international development. She is also member of the Compliance Committee and the Human Resources Committee.
    Ms Leslie A Desjardins Non-Executive Director Nov 2015
    Mrs Desjardins is a former international finance executive with experience in business performance and growth. Mrs Desjardins was formerly the Chief Financial Officer of Amcor Limited. Prior to Amcor, she held executive roles at General Motors Corporation, in Canada, the United States and Australia, including Chief Financial Officer GM Holden, Controller for GM North America and Finance Director for GM's manufacturing facilities in North America. Mrs Desjardins has experience in finance, M&A, strategy, government relations and global operations. She is the Chair of Compliance Committee, member of the Human Resources Committee and the Governance Committee, M&A Sub-Committee and Share Buyback Sub-Committee.
    Mrs Christina Stercken Non-Executive Director Oct 2017
    Mrs Stercken was a partner at Euro Asia Consulting PartG (EAC) until the end of 2017. In this function, Mrs Stercken helped customers in machinery, automotive, chemical, healthcare and infrastructure industries in strategy, M&A, and operational excellence in growth markets. Before joining EAC, Mrs Stercken served as Managing Director Corporate Finance M&A of Siemens AG. Among other management positions within Siemens AG, she was responsible for the Siemens Task Force China and Head of Public Sector Business Unit at Siemens Business Services. Mrs Stercken started her career in Marketing at BMW Pty. Ltd, South Africa. Mrs Stercken brings a range of competencies relevant to Ansell's strategies, including M&A, broad industry background and business building in developing markets. She is Chair of the Sustainability and Risk Committee and M&A Sub-Committee and member of the Compliance Committee.
    Ms Christine Yingli Yan Non-Executive Director Feb 2019
    Ms Yan is an executive who has had a career at Stanley Black & Decker. Ms Yan has held senior management positions in both the US and China, including Vice President of Sales and Marketing for North America Automotive, President of the Global Automotive Division, President of Americas for the Engineered Fastening division, President of Stanley Storage and Workspace Systems and more recently, President of Asia and Vice President of Integration. Ms Yan brings range of general management experience across different geographies, as well as experience in innovation, business development, sales, digital transformation, and marketing in the business-to- business industry. He is member of the Human Resources Committee and the Governance Committee.
    Mr Neil Salmon Chief Executive OfficerManaging Director Sep 2021
    Mr Salmon had more than 20 years of experience, gained working across a range of roles in a diverse group of international businesses. He spent the first 17 years of his career with Imperial Chemical Industries (ICI) primarily in finance roles based in the UK, South Africa, the USA, and Singapore before serving as Chief Financial Officer of Innophos in New Jersey, USA. Having led Ansell's 7,500 IGBU workforce through a challenging global economic climate, Neil was a contributor to strategies that have allowed the company to pursue its growth trajectory in recent times, notably at the onset of the COVID-19 pandemic. As CEO, he oversees the Company's further strategic development, with a focus on continued innovation and increased sustainability.
    Morten Falkenberg Non-Executive Director Nov 2021
    Mr Falkenberg is an executive with nearly 35 years of leadership experience within FMCG, Telecoms/ Technology, and consumer durable goods companies most recently as CEO of Nobia (Europe's kitchen company) from 2010 until his retirement in 2019. Prior to that Mr Falkenberg held senior positions at Electrolux, Tele Denmark and Coca-Cola and has lived outside his native Denmark in the USA, Israel, Norway, and Sweden. He is also Member of the Compliance Committee and the Sustainability and Risk Committee.
    Ms Catherine Stribley VP Corporate Governance & Social ResponsibilityCompany Secretary Apr 2017
    -
    Renae Leary Chief Commercial Officer - Americas
    -
    Francois le Jeune Chief Commercial Officer EMEA and APAC and Guardian Administration
    -
    Zubair Javeed Chief Financial Officer
    -
    Amanda Manzoni Chief Human Resources Officer
    -
    Michael Gilleece Corporate General Counsel
    -
    Deanna Johnston Global Chief Information Officer
    -
    Darryl Nazareth President of the Healthcare GBU
    -
    Rikard Froberg President of the Industrial GBU
    -
    Augusto Accorsi SBU Vice President and GM HGBU Exam and Single Use
    -
    Angie Phillips SBU Vice President and GM HGBU Surgical and HSS
    -
    Evren Baykal SBU Vice President and GM IGBU Chemical Solutions
    -
    Sean Sweeney SBU Vice President and GM IGBU Mechanical Solutions
    -
    John Marsden Senior Vice President - Global Operations and Global Supply Chain
    -
    Catherine Stribley VP Corporate Governance & Social ResponsibilityCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hsbc Custody Nominees (Australia) Limited 33,834,602 26.68%
    Citicorp Nominees Pty Limited 19,795,585 15.61%
    J P Morgan Nominees Australia Pty Limited 19,427,724 15.32%
    BNP Paribas Noms Pty Ltd <Drp> 5,716,599 4.51%
    National Nominees Limited 5,681,579 4.48%
    HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 905,971 0.71%
    Australian Foundation Investment Company Limited 870,000 0.69%
    Bnp Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <Drp A/C> 820,538 0.65%
    CPU Share Plans Pty Ltd 800,144 0.63%
    Netwealth Investments Limited <Wrap Services A/C> 597,014 0.47%
    Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 386,079 0.31%
    HSBC Custody Nominees (Australia) Limited i 314,117 0.25%
    IOOF Investment Services Limited <IPS Superfund A/C> 303,084 0.24%
    Netwealth Investments Limited <Super Services A/C> 296,305 0.23%
    Citicorp Nominees Pty Limited <Citibank NY ADR Dep A/C> 288,540 0.23%
    The Pavilion Motor Inn of Wagga Wagga Pty Ltd 285,000 0.22%
    Custodial Services Limited <Beneficiaries Holding A/C> 231,474 0.18%
    The Manly Hotels Pty Limited 222,854 0.18%
    HSBC Custody Nominees (Australia) Limited A/C 2 220,184 0.17%
    Australian Executor Trustees Limited <No 1 Account> 178,886 0.14%

    Profile

    since

    Note